Status:
COMPLETED
Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients
Lead Sponsor:
Chulalongkorn University
Conditions:
Hemophilia A
Eligibility:
All Genders
6-20 years
Phase:
PHASE4
Brief Summary
Title: Comparison of different prophylaxis regimens for hemophilia A pediatric patients Principal Investigator: Assistant Professor Darintr Sosothikul, MD Research Question: Does different factor VIII...
Eligibility Criteria
Inclusion
- Hemophilia patients with moderate (factor level 1-3%) or severe (factor level \<1%) severity
Exclusion
- Platelet count less than 100,000 /mm3 or other bleeding tendency
- Hemophilia patients who have FVIII inhibitor \>0.6 BU (modified Nijmogen method)
- Hemophilia patients who have no bleeding symptoms
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT02727647
Start Date
May 1 2015
End Date
March 1 2016
Last Update
April 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Hemato/oncology, Department of Pediatrics, Faculty of medicine,Chulalongkorn U
Bangkok, Pathumwan, Thailand, 10330